Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 7.09% vs -21.74% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 11.69% vs -45.00% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -48.30% vs -14.53% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -7.76% vs -20.37% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 7.09% vs -21.74% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 8.86% vs -50.00% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 11.69% vs -45.00% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 24.59% vs -74.69% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -48.30% vs -14.53% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






